Product Images Imatinib Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Imatinib Mesylate NDC 68382-244 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 5af53579 f57f 40d0 a862 e566aac4c72a 01
Image - 5af53579 f57f 40d0 a862 e566aac4c72a 02
This appears to be a medical or scientific study, as it includes information about progression and a hazard ratio. However, the output is not complete, making it difficult to draw any further conclusions. The text may be describing a clinical trial evaluating the efficacy of two treatments (Imatiibam and IFNeAaCam) in terms of disease progression, with data presented graphically over a period of 72 months. Without seeing the full text, further analysis is not possible.*
Image - 5af53579 f57f 40d0 a862 e566aac4c72a 03
Not available.*
label - 5af53579 f57f 40d0 a862 e566aac4c72a 04
GTIN: 00, Lot: 00000, and Exp: DOMMMYYYY suggest that the given text refers to a pharmaceutical product called Imatinib Mesylate Tablets. Each film-coated tablet contains 100 mg of Imatinib free base. The text further mentions its usual dosage and storage conditions. The product is manufactured by Calla Healthcare Ltd, based in Ahmedabad, India, and is distributed by Zyaus Pharmaceuticals (USA) Inc, located in Pennington, NJ 08534. Note that some characters in the Exp field are not readable.*
label - 5af53579 f57f 40d0 a862 e566aac4c72a 05
Imatinib Mesylate Tablets with 400mg of imatinib per tablet manufactured by Carila Healthcare Ltd, Anmedatad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. with NDC 68382-245-16. It comes in a package of 90 tablets and the usual dosage is found in the package insert. It should be kept in a tight container at a temperature between 16°C to 30°C, with permitted excursions. The drug must be kept out of the reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.